Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-25 @ 4:14 AM
Ignite Modification Date:
2025-12-25 @ 4:14 AM
NCT ID:
NCT06417320
Brief Summary:
The goal of this clinical trial is to evaluate the effect of ACE inhibitors and SGLT-2 inhibitors on:
1. Proteinuria
2. Renal survival indices
Detailed Description:
This is a randomized, double blind study. Patients are randomized to receive oral ACE inhibitors or combined ACEI and SGLT-2inhibitrs once daily for12 weeks.
Study:
NCT06417320
Study Brief:
Protocol Section:
NCT06417320